Amneal Pharmaceuticals (AMRX) Operating Margin Growth (3y) (2020 - 2026)
Amneal Pharmaceuticals (AMRX) Operating Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1,673.00 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -37.00 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1,442.00 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 13,036.00 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 5,091.00 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5,310.00 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -11,841.00 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -698.00 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2,466.00 |
| 10 | Amneal Pharmaceuticals | 4.66 Bn | 4.65 Bn | 320.11 Mn | 1,344.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,344.00 |
| Dec 31, 2025 | 1,603.00 |
| Sep 30, 2025 | 84.00 |
| Jun 30, 2025 | 5,088.00 |
| Mar 31, 2025 | -78,919.00 |
| Dec 31, 2024 | 829.00 |
| Sep 30, 2024 | 725.00 |
| Jun 30, 2024 | 106.00 |
| Mar 31, 2024 | -1,094.00 |
| Dec 31, 2023 | -338.00 |
| Sep 30, 2023 | 1,173.00 |
| Jun 30, 2023 | 1,105.00 |
| Mar 31, 2023 | -541.00 |
| Dec 31, 2022 | 355.00 |
| Sep 30, 2022 | 3,781.00 |
| Jun 30, 2022 | -3,083.00 |
| Mar 31, 2022 | 82,477.00 |
| Dec 31, 2021 | -260.00 |
| Sep 30, 2021 | -1,025.00 |
| Jun 30, 2021 | 5,630.00 |